Elizabeth B Burgener

Elizabeth B Burgener, MD is a pediatric pulmonologist and physician scientist. After receiving her B.A. at Stanford University, she completed medical school at the University of Texas Health Science Center at San Antonio in 2011. She then returned to Stanford for residency in Pediatrics followed by a year as a Pediatric Chief Resident prior to fellowship in pediatric pulmonary medicine during which she also completed post-doctoral training in microbiology and immunology in the Bollyky Lab. She spent another 5 years at Stanford developing her research program before she moved to Children’s Hospital of Los Angeles and Keck School of Medicine at USC in summer of 2023. She is currently an Assistant Professor in the division of Pediatric Pulmonology & Sleep Medicine in the department of Pediatrics where she treats patients with pulmonary disease as well as conducting translational research focused on infection and bacteriophage in the cystic fibrosis airways.

• Cystic Fibrosis Foundation : Harry Shwachman Clinical Investigator Award, 2020-2023
• Vertex Pharmaceuticals, Inc. : Cystic Fibrosis Research Innovation Award, 2019
• Department of Pediatrics, Stanford University : Bridge to K Award, 2018-2021
• Francis Family Foundation: Parker B Francis Fellowship, 2018-2021
• Respiratory Disease Young Investigators Forum, National Jewish Health, Washington, DC: First Place in Clinical Research, 2018
• Stanford University: T32 Program In Pulmonary Biology, 2016-2018
• Translational Research and Applied Medicine, Stanford University: Pilot Grant, 2016-2018
• Maternal Child Health Institute, Stanford University: Clinical Trainee Award, 2015-2018
• UTHSCSA: Alpha Omega Alpha, 2011

• Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding bioRxiv. 2024 Mar 10. . View in PubMed
• Highly effective cystic fibrosis transmembrane conductance (regulator) modulator therapy: shifting the curve for most while leaving some further behind Curr Opin Pediatr. 2024 Feb 16. . View in PubMed
• The Inovirus Pf4 Triggers Antiviral Responses and Disrupts the Proliferation of Airway Basal Epithelial Cells Viruses. 2024 Jan 22; 16(1). . View in PubMed
• Targeted deletion of Pf prophages from diverse Pseudomonas aeruginosa isolates impacts quorum sensing and virulence traits bioRxiv. 2023 Nov 19. . View in PubMed
• Delivering a New Future for People With Cystic Fibrosis Pediatrics. 2023 10 01; 152(4). . View in PubMed
• Bacteriophage and Bacterial Susceptibility, Resistance, and Tolerance to Antibiotics Pharmaceutics. 2022 Jul 07; 14(7). . View in PubMed
• Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections medRxiv. 2022 Apr 04. . View in PubMed
• Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections JCI Insight. 2022 06 22; 7(12). . View in PubMed
• Oral hymecromone decreases hyaluronan in human study participants J Clin Invest. 2022 05 02; 132(9). . View in PubMed
• Filamentous bacteriophage delays healing of Pseudomonas-infected wounds Cell Rep Med. 2022 06 21; 3(6):100656. . View in PubMed
• Biochemical and Biophysical Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections medRxiv. 2021 Aug 19. . View in PubMed
• Filamentous Bacteriophages and the Competitive Interaction between Pseudomonas aeruginosa Strains under Antibiotic Treatment: a Modeling Study mSystems. 2021 Jun 29; 6(3):e0019321. . View in PubMed
• Dynamic light scattering microrheology for soft and living materials Soft Matter. 2021 Feb 21; 17(7):1929-1939. . View in PubMed
• The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies Viruses. 2021 06 29; 13(7). . View in PubMed
• Area under the curve achievement of once daily tobramycin in children with cystic fibrosis during clinical care Pediatr Pulmonol. 2020 12; 55(12):3343-3350. . View in PubMed
• Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections Front Immunol. 2020; 11:244. . View in PubMed
• Methods for Extraction and Detection of Pf Bacteriophage DNA from the Sputum of Patients with Cystic Fibrosis Phage (New Rochelle). 2020 06 01; 1(2):100-108. . View in PubMed
• Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis Sci Transl Med. 2019 04 17; 11(488). . View in PubMed
• Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis Curr Opin Pediatr. 2018 06; 30(3):372-377. . View in PubMed
• Teaching High-Value Care in Pediatrics: A National Survey of Current Practices and Guide for Future Curriculum Development J Grad Med Educ. 2017 Dec; 9(6):741-747. . View in PubMed
• Clinical characteristics and outcomes of pediatric patients with CMV DNA detection in bronchoalveolar lavage fluid Pediatr Pulmonol. 2017 01; 52(1):112-118. . View in PubMed
• Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis Open Forum Infect Dis. 2016 Jan; 3(1):ofv212. . View in PubMed
• Index of suspicion Pediatr Rev. 2014 Oct; 35(10):439-46. . View in PubMed

• Beringer, Paul
• Maher, Toby